Manulife (Manufacturers Life Insurance)
OMED

Manulife (Manufacturers Life Insurance)’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-768
Closed -$2K – 4353
2018
Q2 		$2K Hold
768
– – ﹤0.01% 4233
2018
Q1 		$2K Hold
768
– – ﹤0.01% 4258
2017
Q4 		$3K Sell
768
-1,994
-72% -$8.68K ﹤0.01% 4210
2017
Q3 		$12K Buy
2,762
+1,490
+117% +$6.04K ﹤0.01% 3793
2017
Q2 		$4K Sell
1,272
-17,778
-93% -$73.8K ﹤0.01% 4022
2017
Q1 		$175K Buy
19,050
+1,729
+10% +$15.2K ﹤0.01% 2916
2016
Q4 		$133K Buy
17,321
+3,672
+27% +$33.7K ﹤0.01% 3078
2016
Q3 		$156K Hold
13,649
– – ﹤0.01% 2966
2016
Q2 		$168K Buy
13,649
+1,216
+10% +$14.8K ﹤0.01% 2856
2016
Q1 		$120K Buy
12,433
+335
+3% +$3.93K ﹤0.01% 2954
2015
Q4 		$273 Buy
12,098
+289
+2% +$5.92K ﹤0.01% 2428
2015
Q3 		$196 Buy
11,809
+227
+2% +$4.55K ﹤0.01% 2671
2015
Q2 		$261 Buy
11,582
+2,490
+27% +$61.4K ﹤0.01% 2638
2015
Q1 		$234 Buy
9,092
+303
+3% +$7.68K ﹤0.01% 2618
2014
Q4 		$191 Sell
8,789
-144
-2% -$2.95K ﹤0.01% 2681
2014
Q3 		$169 Buy
8,933
+120
+1% +$2.41K ﹤0.01% 2751
2014
Q2 		$205K Buy
8,813
+4,504
+105% +$111K ﹤0.01% 2701
2014
Q1 		$145 Buy
4,309
+4,132
+2,334% +$139K ﹤0.01% 2906
2013
Q4 		$5 Hold
177
– – ﹤0.01% 3555
2013
Q3 		$3 Buy
+177
New +$3.28K ﹤0.01% 3497

Other funds holding OMED

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s OMED Position: Q3 2018 in Review

Manulife (Manufacturers Life Insurance) sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2018, closing a stake of 768 shares — an estimated $2K sold.

Manulife (Manufacturers Life Insurance) first reported a position in OMED in Q3 2013 and held it in 20 quarters. The position peaked at $205K in Q2 2014. 54 funds tracked by Wall St. Rank hold OMED as of Q3 2018.

  • Manulife (Manufacturers Life Insurance) reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 768 OncoMed Pharmaceuticals, Inc. shares in Q3 2018, an estimated $2K.
  • Manulife (Manufacturers Life Insurance) first reported a position in OncoMed Pharmaceuticals, Inc. in Q3 2013 and held it in 20 quarters.
  • Manulife (Manufacturers Life Insurance)'s OncoMed Pharmaceuticals, Inc. position peaked at $205K in Q2 2014.
  • 54 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2018.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2018, filed 14 Nov 2018.